Cresset Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76M Buy
+11,934
New +$3.17M 0.02% 381
2026
Q1
Sell
-2,253
Closed -$375K 1811
2025
Q4
$375K Sell
2,253
-6,649
-75% -$1.11M ﹤0.01% 1201
2025
Q3
$1.74M Buy
8,902
+1,398
+19% +$230K 0.01% 577
2025
Q2
$679K Buy
+7,504
New +$593K ﹤0.01% 806
2025
Q1
Sell
-1,628
Closed -$216K 1879
2024
Q4
$216K Buy
+1,628
New +$153K ﹤0.01% 1525

Other funds holding ALAB

Cresset Asset Management's ALAB Position: Q2 2026 in Review

Cresset Asset Management opened a new position in Astera Labs (ALAB) in Q2 2026: 11,934 shares worth $5.76M. The stake represents 0.02% of the portfolio and ranks #381 among its holdings. This is a return to the name: Cresset Asset Management previously reported a position in ALAB as recently as Q4 2025.

Cresset Asset Management first reported a position in ALAB in Q4 2024 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Cresset Asset Management held 11,934 shares of Astera Labs worth $5.76M as of Q2 2026.
  • Astera Labs was a new Cresset Asset Management position in Q2 2026.
  • Astera Labs made up 0.02% of Cresset Asset Management's portfolio in Q2 2026, its #381 holding.
  • Cresset Asset Management first reported a position in Astera Labs in Q4 2024 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.